Literature DB >> 16333326

A molecular view of cytotoxic T lymphocyte induced killing.

R Chris Bleackley1.   

Abstract

Cytotoxic T lymphocytes (CTLs) search out and destroy pathogenic cells, such as those infected with viruses. The biochemistry laboratory at the University of Alberta (Edmonton, Alta.) studies the molecular mechanisms used by these effectors, and this review covers research on this topic primarily from this group. Research there began with the discovery of the granzyme genes and the realization that granzyme B (GrB) had an unusual substrate specificity. Cleavage at aspartate residues gave us the clue that caspases, key regulators of apoptosis, were important substrates. However, it is now clear that mitochondria are also important in controlling granzyme-induced apoptosis. This led to the discovery that the proapoptotic member of the Bcl2 family, Bid, is also activated by GrB. Cleaved Bid then translocates to the mitochondria, resulting in the release of antagonists of inhibitors of apoptosis proteins. The evolution of our understanding of the molecular basis of CTL killing is presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333326     DOI: 10.1139/o05-146

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  12 in total

1.  Imaging of lytic granule exocytosis in CD8+ cytotoxic T lymphocytes reveals a modified form of full fusion.

Authors:  Jose A Martina; Xufeng S Wu; Marta Catalfamo; Takeshi Sakamoto; Chang Yi; John A Hammer
Journal:  Cell Immunol       Date:  2011-07-24       Impact factor: 4.868

2.  Mouse cytotoxic T cell-derived granzyme B activates the mitochondrial cell death pathway in a Bim-dependent fashion.

Authors:  Elena Catalán; Paula Jaime-Sánchez; Nacho Aguiló; Markus M Simon; Christopher J Froelich; Julián Pardo
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

Review 3.  Endothelial cells in allograft rejection.

Authors:  Rafia S Al-Lamki; John R Bradley; Jordan S Pober
Journal:  Transplantation       Date:  2008-11-27       Impact factor: 4.939

4.  Antigen-specific primed cytotoxic T cells eliminate tumour cells in vivo and prevent tumour development, regardless of the presence of anti-apoptotic mutations conferring drug resistance.

Authors:  Paula Jaime-Sánchez; Elena Catalán; Iratxe Uranga-Murillo; Nacho Aguiló; Llipsy Santiago; Pilar M Lanuza; Diego de Miguel; Maykel A Arias; Julián Pardo
Journal:  Cell Death Differ       Date:  2018-05-09       Impact factor: 15.828

5.  Molecular detection of targeted major histocompatibility complex I-bound peptides using a probabilistic measure and nanospray MS3 on a hybrid quadrupole-linear ion trap.

Authors:  Bruce Reinhold; Derin B Keskin; Ellis L Reinherz
Journal:  Anal Chem       Date:  2010-10-08       Impact factor: 6.986

6.  Granzyme B inhibits vaccinia virus production through proteolytic cleavage of eukaryotic initiation factor 4 gamma 3.

Authors:  Marcelo Marcet-Palacios; Brenda Lee Duggan; Irene Shostak; Michele Barry; Tracy Geskes; John A Wilkins; Akiko Yanagiya; Nahum Sonenberg; R Chris Bleackley
Journal:  PLoS Pathog       Date:  2011-12-15       Impact factor: 6.823

7.  Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3+)/activated cytotoxic T lymphocyte (granzyme B+) ratio on resected left-sided pancreatic cancer.

Authors:  Ho Kyoung Hwang; Hyoung-Il Kim; Se Hoon Kim; Junjeong Choi; Chang Moo Kang; Kyung Sik Kim; Woo Jung Lee
Journal:  Oncol Lett       Date:  2016-10-13       Impact factor: 2.967

Review 8.  Metastatic melanoma - a review of current and future drugs.

Authors:  Tiago Rodrigues Velho
Journal:  Drugs Context       Date:  2012-11-19

9.  Yonsei Criteria, a Potential Linkage to Intratumoral Foxp3⁺/CD8⁺ Ratio for the Prediction of Oncologic Outcomes in Resected Left-Sided Pancreatic Cancer.

Authors:  Ho Kyoung Hwang; Sung Hwan Lee; Hyoung Il Kim; Se Hoon Kim; Junjeong Choi; Chang Moo Kang; Woo Jung Lee
Journal:  Yonsei Med J       Date:  2020-04       Impact factor: 2.759

Review 10.  Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.

Authors:  Wendy Anne Boivin; Dawn Michelle Cooper; Paul Ryan Hiebert; David James Granville
Journal:  Lab Invest       Date:  2009-09-21       Impact factor: 5.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.